1. Home
  2. OSPN vs DCTH Comparison

OSPN vs DCTH Comparison

Compare OSPN & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OneSpan Inc.

OSPN

OneSpan Inc.

N/A

Current Price

$18.23

Market Cap

561.7M

Sector

Technology

ML Signal

N/A

DCTH

Delcath Systems Inc.

N/A

Current Price

$15.26

Market Cap

578.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OSPN
DCTH
Founded
1991
1988
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
561.7M
578.4M
IPO Year
2000
2015

Fundamental Metrics

Financial Performance
Metric
OSPN
DCTH
Price
$18.23
$15.26
Analyst Decision
Buy
Strong Buy
Analyst Count
4
5
Target Price
$18.00
★ $24.00
AVG Volume (30 Days)
★ 491.9K
306.8K
Earning Date
10-29-2026
11-03-2026
Dividend Yield
★ 2.89%
N/A
EPS Growth
28.77
★ 107.53
EPS
★ 0.48
0.04
Revenue
★ $243,180,000.00
N/A
Revenue This Year
$2.90
$24.61
Revenue Next Year
$2.36
$24.27
P/E Ratio
★ $37.52
$376.00
Revenue Growth
N/A
N/A
52 Week Low
$10.07
$8.12
52 Week High
$18.83
$17.42

Technical Indicators

Market Signals
Indicator
OSPN
DCTH
Relative Strength Index (RSI) 59.90 43.91
Support Level $17.05 $9.98
Resistance Level $18.28 $16.51
Average True Range (ATR) 0.54 0.53
MACD -0.04 -0.11
Stochastic Oscillator 67.61 39.01

Price Performance

Historical Comparison
OSPN
DCTH

About OSPN OneSpan Inc.

OneSpan Inc is a provider of information technology security solutions for banking and financial services and application security markets. The company build secure, seamless, and trusted digital experiences through two solution portfolios: Cybersecurity solutions engaged in protecting identities, securing mobile apps, and safeguarding access through high-assurance authentication, threat intelligence, fraud prevention, and robust mobile app protection, defending users, devices, and applications against sophisticated attacks, while Digital agreement solutions focuses on streamlining workflows with secure e-signatures, identity verification, and smart digital forms, built to enable speed, compliance and other customer experiences.

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. The company is focused on the treatment of primary and metastatic liver cancers. The firm's product include Melphalan Hydrochloride, Hepzato for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

Share on Social Networks: